Ptc Therapeutics (PTCT) Gross Profit (2017 - 2025)
Historic Gross Profit for Ptc Therapeutics (PTCT) over the last 10 years, with Q3 2025 value amounting to $195.2 million.
- Ptc Therapeutics' Gross Profit rose 499.52% to $195.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 16762.96%. This contributed to the annual value of $749.4 million for FY2024, which is 1409.48% down from last year.
- Latest data reveals that Ptc Therapeutics reported Gross Profit of $195.2 million as of Q3 2025, which was up 499.52% from $167.5 million recorded in Q2 2025.
- Ptc Therapeutics' Gross Profit's 5-year high stood at $1.2 billion during Q1 2025, with a 5-year trough of -$15.5 million in Q2 2024.
- Its 5-year average for Gross Profit is $216.9 million, with a median of $185.9 million in 2024.
- Per our database at Business Quant, Ptc Therapeutics' Gross Profit crashed by 10772.19% in 2024 and then surged by 117847.62% in 2025.
- Quarter analysis of 5 years shows Ptc Therapeutics' Gross Profit stood at $155.9 million in 2021, then increased by 0.4% to $156.5 million in 2022, then soared by 77.57% to $277.9 million in 2023, then dropped by 29.16% to $196.9 million in 2024, then dropped by 0.84% to $195.2 million in 2025.
- Its Gross Profit stands at $195.2 million for Q3 2025, versus $167.5 million for Q2 2025 and $1.2 billion for Q1 2025.